NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Earnings & Estimates
NASDAQ:NRSN - IL0011809592 - Common Stock
1.12 USD
+0 (+0.01%)
1.1298 USD
+0.01 (+0.87%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 206.23% | N/A 103.98% | N/A 2,680.38% | N/A 114.64% | N/A 74.36% | N/A 20.21% | |||||||
| EBITDA YoY % growth | -1.24M | -2.89M -133.06% | -5.59M -93.43% | -13.46M -140.79% | -12.028M 10.64% | -9.88M 17.86% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.24M | -2.89M -133.06% | -5.59M -93.43% | -13.55M -142.40% | -12.049M 11.08% | -9.902M 17.82% | N/A 9.08% | N/A 14.70% | N/A -20.57% | N/A 37.43% | N/A 61.81% | N/A 420.47% | N/A 159.69% | N/A 61.69% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -0.54 37.72% | N/A 33.89% | N/A 42.86% | N/A 5.00% | N/A -31.58% | N/A 1,320.00% | N/A 102.95% | N/A 64.46% | N/A 20.04% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.06 49.00% | -0.05 23.50% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.236M -6.14% | -1.948M 80.33% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.06 62.50% | -0.12 | 0.06 | 48.85% |
| Q3 2024 Q2Q % growth | -0.11 -210.00% | -0.16 | 0.05 | 32.60% |
| Q2 2024 Q2Q % growth | -0.02 95.45% | -0.20 | 0.18 | 90.20% |
| Q1 2024 Q2Q % growth | -0.35 | -0.21 | -0.14 | -67.38% |
| Q4 2023 Q2Q % growth | -0.16 | -0.20 | 0.04 | 21.57% |
| Q3 2023 Q2Q % growth | 0.10 | -0.25 | 0.35 | 140.02% |
| Q2 2023 Q2Q % growth | -0.44 -41.94% | -0.29 | -0.15 | -54.06% |
| Q1 2022 Q2Q % growth | -0.24 | -0.18 | -0.06 | -30.72% |
| Q3 2021 Q2Q % growth | -0.24 | -0.21 | -0.03 | -12.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 38.89% | 63.33% | 30.46% | 34.37% |
| Revenue | N/A | N/A | N/A | N/A |